Waiting
登录处理中...

Trial ends in Request Full Access Tell Your Colleague About Jove
Journal / Cancer Research / EGFR-Mutant NSCLC Hasta Kaynaklı Organoidlerde…
JoVE Journal
Cancer Research

这篇 内容 是免费权限的.

JoVE Journal Cancer Research
EGFR-Mutant NSCLC Hasta Kaynaklı Organoidlerde Hedefe Yönelik Tedavilere Duyarlılığın Profillenmesi
Lung Tumor Cell Recruitment Assay
Journal (Cancer Research)
Lung Tumor Cell Recruitment Assay
Detection of Protease Activity by Fluorescent Peptide Zymography
Journal (Cancer Research)
Detection of Protease Activity by Fluorescent Peptide Zymography
 
Click here for the English version

EGFR-Mutant NSCLC Hasta Kaynaklı Organoidlerde Hedefe Yönelik Tedavilere Duyarlılığın Profillenmesi

Article DOI: 10.3791/63039-v • 08:52 min • November 22nd, 2021
November 22nd, 2021 •
1,2,3, 1,2, 1,2,3, 1,2,3
1Department of Medicine, University of California, San Francisco, 2Helen Diller Family Comprehensive Cancer Center, University of California, San Francisco, 3Department of Cellular and Molecular Pharmacology, University of California, San Francisco

章节

总结概括
Automatic Translation

Please note that all translations are automatically generated.

Click here for the English version.

Bu protokol, NSCLC hasta kaynaklı organoid modellerde hedeflenen sinyal inhibitörlerine karşı ilaç duyarlılıklarının standartlaştırılmış bir değerlendirmesini açıklamaktadır.

Tags

Kanser Araştırmaları Sayı 177 Organoid akciğer organoidi PDO NSCLC akciğer kanseri osimertinib EGFR hedeflenen İnhibitör direnç
Read Article

Get cutting-edge science videos from JoVE sent straight to your inbox every month.

Waiting X
Simple Hit Counter